Research
Print page Print page
Switch language
Rigshospitalet - a part of Copenhagen University Hospital
Published

Evaluation of a screening algorithm for detection of diabetic retinopathy based on quantitation of retinal pathological elements

Research output: Contribution to journalConference abstract in journalResearchpeer-review

  1. Validating Optos® ultra wide-field imaging against conventional Topcon® imaging

    Research output: Contribution to journalConference abstract in journalResearchpeer-review

  1. Optos wide-field imaging versus conventional camera imaging in Danish patients with type 2 diabetes

    Research output: Contribution to journalJournal articleResearchpeer-review

  2. Evaluating an algorithm for screening intervals for diabetic retinopathy and the effect of HbA1c and hypertension

    Research output: Contribution to journalConference abstract in journalResearchpeer-review

  3. Assessment of diurnal melatonin, cortisol, activity, and sleep-wake cycle in patients with and without diabetic retinopathy

    Research output: Contribution to journalJournal articleResearchpeer-review

  4. Deep learning for classification of types of retinal fundus images

    Research output: Contribution to conferenceConference abstract for conferenceResearchpeer-review

  5. Diabetic Macular Edema Treated with Anti–Vascular Endothelial Growth Factor: Considerations Related to Nonimprovers

    Research output: Contribution to journalJournal articleResearchpeer-review

View graph of relations
Purpose : Diabetic retinopathy (DR) screening is generally recommended once yearly. However, among diabetes patients with glycemic dysregulation, it is recommended to reduce the interval length. At Steno Diabetes Center Copenhagen (SDCC), a diabetes clinic in Denmark, screening intervals are based on quantitation of pathological findings in both the macula and peripheral retina, resulting in individualized screening intervals, not necessarily following the recommended guidelines. We followed 6000 patients between 1/1-2003 – 1/5-2017 at SDCC and assessed whether the individualized screening interval lengths were adequate for optimal patient outcomes. Methods : All screening intervals with planned interval lengths ≥12 months were assessed for occurrence of adverse events, defined as; 1)DR progression requiring treatment, at the following screening date 2)DR-related hospital contact or photocoagulation treatment within the planned interval According to guidelines, patients were considered dysregulated if they had HbA1c levels ≥53 mmol/mol and/or hypertension (>130/80 mmHg) before the beginning of an interval. Results : The average interval length was longer than recommended; 19.9 (SD 7.6) months among well-regulated patients and 19.4 (SD 7.1) months among dysregulated patients. Out of 20,251 screening intervals, 17,534 (87%) followed the planned interval. Among screenings following the planned interval, only 0.5% (n=88) resulted in an adverse event. Dysregulated patient intervals (82% of all intervals) experienced a significantly higher proportion of adverse events compared with intervals of well-regulated patients (0.55% vs. 0.28%, p<0.05). Adverse events were more frequent among type 2 diabetes compared with type 1 diabetes (0.71% vs. 0.40%, p<0.05), if screened within the planned interval. 1.62% experienced an adverse event if screened beyond the planned interval. Conclusions : The present study supports the validity of the SDCC algorithm, introducing individualized screening intervals for patients with no to moderate DR, even though this resulted in longer than recommended screening intervals for both well-regulated and dysregulated patients. Although intervals among dysregulated patients more frequently resulted in an adverse event, the proportion of adverse events was still less than 1%. Further analyses will assess the optimal screening interval for the individual patient
Original languageEnglish
JournalInvestigative Ophthalmology & Visual Science
Volume60
Issue number9
Pages (from-to)4798
Number of pages1
ISSN0146-0404
Publication statusPublished - Jul 2019

ID: 58440993